EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic, Germany, Italy and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
19/03/2026 - 9:00 am to 10:30 am
20/03/2026 - 9:00 am to 10:30 am
Room 118
Jonathan Underhill
Link to EAHP Statements
tba
Abstract
The safe and appropriate use of hormone-replacement therapy (HRT) in women is one of the most misunderstood treatments in healthcare. The WHI study, where older HRT preparations were studied, raised concerns about the safety of HRT. However, a number of studies published since then provide reassurance about these safety concerns, as well as showing good evidence of the benefits women can obtain from the sensible use of modern HRT preparations.
Fluctuating hormone levels during perimenopause and menopause are associated with an increased prevalence of anxiety, low mood and depression in midlife. Around 1 in 3 perimenopausal and menopausal women are offered or prescribed antidepressants or anxiolytics for negative mood symptoms. There is no clear evidence of benefit for antidepressants when used to treat low mood in perimenopausal or menopausal women not diagnosed with clinical depression. Offering HRT to perimenopausal and menopausal women with psychological symptoms can improve quality of life and enables deprescribing in women already initiated on antidepressant therapy, reducing the risk of side effects and harms associated with long term antidepressant use.
Overview: This interactive, workshop will discuss the latest evidence for the use of natural, body identical HRT. It will also use specific cases to explore the practical aspects of menopause care and demonstrate how to deprescribe in certain situations. The cases will allow for brief discussions regarding the therapeutics at play. The session will also allow for and include brief discussion around decision making and communication, focusing on how to have meaningful conversations with patients, carers and other healthcare professionals. It will also highlight the key components of a menopause consultation.
The session will also explore the role of a menopause specialist pharmacist and how they approach consultations in a person-centred way ensuring shared decision making and individualised care.
Learning objectives
After the session, the participant should be able to:
– Improve understanding of perimenopause and menopause care and disease prevention.
– Identify the principles of management of perimenopausal and menopausal symptoms.
– Learn to recognise and deal with specific circumstances for deprescribing in perimenopause and menopause care in certain patients linked to antidepressants and anxiolytics.
Educational need addressed
This session will address the value of having meaningful conversations with patients, carers and healthcare professionals and how this can enable pharmacy professionals to become more confident in considering options for management of perimenopausal and menopausal symptoms.
Keywords
tba
